简体中文
Science & Technologies / Newsroom / Ordering Info / Career / Contact Us
Products Services Quality System Culture About Us
中文 / English
Login Register

Newsroom

Home Newsroom CHO CD02, CHO CD04, and CHO Feed02 were launched
News

May 1, 2018

CHO CD02, CHO CD04, and CHO Feed02 were launched










Latest Articles
News October 19, 2021

Congratulation!! | Quacell won the title of excellent enterprise in the 10th China Innovation and Entrepreneurship Competition (growth group)!

Learn More
News August 16, 2021

News | QuaCell Biotechnology announced that it had completed nearly 200 million yuan of round B financing

Recently, Quacell Biotechnology Co., Ltd. announced the completion of nearly 200 million yuan of round B financing. This round of investment will be used to strengthen product R & D, improve technological innovation and production capacity as well as high-standard industrial order delivery capacity.
Learn More
News June 25, 2021

Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open

June 25, 2021 / Quacell Newsroom /- Dr. Poon, CEO of Quacell Biotechnology Co., Ltd. was invited by Re: Gen Open to be selected as Associate Editor.
Learn More
News May 25, 2021

Conclusion | Biofuture2021

The two-day Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference came to a successful conclusion.
Learn More
News May 21, 2021

BIG EVENETS. Day 2 | Biofuture 2021

Quacell Biotechnology will continue to show you more latest information about our products in the #B21 booth
Learn More
News May 20, 2021

BIG EVENETS. Day 1 | Biofuture 2021

Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference held in Crowne Plaza Shanghai Jiangong Pujiang Hotel
Learn More